Idarucizumab in major trauma patients: a single centre real life experience.

Daniel OberladstätterWolfgang VoelckelMartin BruckbauerJohannes ZipperleOliver GrottkeBernhard ZieglerHerbert Schöchl

Published in: European journal of trauma and emergency surgery : official publication of the European Trauma Society (2019)

In trauma patients under DAB prior to injury, IDA decreased DAB plasma levels and normalized coagulation parameters. IDA appears to be safe, and no serious side effects were observed in this small cohort of patients.

Keyphrases

trauma patients
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported